Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Elevance Health in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Elevance Health’s 10-Q, filed July 15, 2026.
- Filed
- Jul 15, 2026, 11:27 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001156039-26-000060
| Line item | Three Months Ended June 30 / 2026 | Three Months Ended June 30 / 2025 | Six Months Ended June 30 / 2026 | Six Months Ended June 30 / 2025 |
|---|---|---|---|---|
| Cost of products sold | 5,492 | 5,293 | 10,955 | 10,276 |
| Operating expense | 5,547 | 4,997 | 11,877 | 10,297 |
| Interest expense | 364 | 341 | 721 | 685 |
| Amortization of other intangible assets | 110 | 147 | 222 | 302 |
| Total expenses | 48,537 | 47,484 | 96,414 | 93,578 |
| Income before income tax expense | 1,937 | 2,292 | 4,241 | 5,089 |
| Income tax expense | 483 | 548 | 1,027 | 1,161 |
| Net income | 1,454 | 1,744 | 3,214 | 3,928 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elevance Health's D&A?
- Elevance Health (ELV) reported D&A of $110M in Q2 2026.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Elevance Health's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude